Draft:Jes Dietrich
| Submission declined on 1 May 2025 by WormEater13 (talk). This submission's references do not show that the subject qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published, reliable, secondary sources that are independent of the subject (see the guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see technical help and learn about mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission is not adequately supported by reliable sources. Reliable sources are required so that information can be verified. If you need help with referencing, please see Referencing for beginners and Citing sources.
Where to get help
How to improve a draft
You can also browse Wikipedia:Featured articles and Wikipedia:Good articles to find examples of Wikipedia's best writing on topics similar to your proposed article. Improving your odds of a speedy review To improve your odds of a faster review, tag your draft with relevant WikiProject tags using the button below. This will let reviewers know a new draft has been submitted in their area of interest. For instance, if you wrote about a female astronomer, you would want to add the Biography, Astronomy, and Women scientists tags. Editor resources
|  |
Comment: See WP:COI. WormEater13 (talk • contribs) 19:04, 1 May 2025 (UTC)
Jes Dietrich | |
|---|---|
| Education | University of Copenhagen |
| Employer | Statens Serum Institut |
| Title | Infection immunologist |
Jes Dietrich is an infection immunologist working for Statens Serum Institut in Denmark. He went to the University of Copenhagen.[1]
He has published articles on topics such as streptococci, tuberculosis, polio and recently Chlamydia trachomatis.
In 2016, Jes launched a project investigating the immune response to genital infection with Chlamydia trachomatis (Ct). This work received funding from the Danish Council for Independent Research (DFF) in both 2019 and 2022 to explore the role of Th17 T cells in Ct infection. Additionally, Jes’s research group secured EU funding through the VacPath project to study the involvement of CD8 T cells in chlamydia infections and to evaluate vaccines designed to induce CD8 T cell responses.
Jes is also engaged in research aimed at identifying the optimal immune response to Streptococcus infections and in the development of a vaccine targeting this pathogen.